April 22, 2025 | 12:00 p.m. – 1:00 p.m. HE
Preview
There is a pot-pourri of questions surrounding the new USP updates <797> And many pharmacists and pharmacy technicians are not clear about how to get answers. As more installations use technology and integrate a designated person, it is crucial that best practices for using use cases between pharmacists, pharmacy technicians and drug safety officers, so that these health professionals can learn ways to overcome common challenges in different scenarios. This educational activity will describe opportunities for implementing and validate technology for sterile composition, achieve organizational membership and describe a user case where technology has been integrated safely and efficiently and USP <797> Compliant. This activity will also highlight an example of incorporation of a designated person and their experiences, challenges and future opportunities.
Registration is required for this webinar.
Register
Target audience
The target audience of education is pharmacists, pharmacy technicians and drug safety officers working in hospitals and health systems, including all environments responsible for preparation, labeling, packaging, storage and distribution of composed sterile preparations. This can also be interesting for infection control practitioners and risk management in hospitals and health systems.
Learning objectives
- Evaluate opportunities to securely and effectively integrate technology into the alignment of sterile composition with USP standards <797>.
- Apply best practices to overcome challenges with the use of designated people.
Agenda
-
12:00 p.m. – Welcome and presentation
Patricia Kienle -
12:05 p.m. – The roadmap for the implementation of USP technology <797>
Kevin Hansen and George Smith -
12:35 p.m. – A day in the life of a designated person
Glen Gard -
12:50 p.m. – Discussion of teachers, questions and answers
All teachers
Speakers
Patricia C. Kienle, Pharmd, MS, BCSCP
ModeratorDirector, accreditation and safety of drugs, Cardinal Health, Wilkes-Barre, Pennsylvania
Patricia Kienle is director of accreditation and safety of drugs for Cardinal Health. She graduated in pharmacy from Philadelphia College of Pharmacy and Science and a master’s degree in public administration from Marywood University in Scranton, Pennsylvania. She is the author of The chapter <795> Book Answer,, The chapter <797> Book AnswerAnd The chapter <800> Book Answer and co-author of Meeting of accreditation standards: a pharmacy preparation guide. With more than 600 invited presentations and 100 publications, she is particularly interested in the safety of drugs, the composition of sterile preparations, accreditation and regulatory problems.
Kevin N. Hansen, Pharmd, MS, BCSCP
Senior director, Pharmacy Compounding Services, First Inc., Charlotte, Caroline du Nord
Kevin Hansen is principal director of the first Inc. pharmacy composition services, based in Charlotte, in North Carolina. In this role, he supports members by providing an assessment and audits of the 503B outsourcing facilities and services related to the insufficient composition. He obtained his doctorate in pharmacy from LECOM, finished a PGY1 / PGY2 / MS Health-System Pharmacy Administration and Leadership Presidency at the University of North Carolina MEDICAL Center, and is a sterile aggravating pharmacist certified by the board of directors.
George Smith, Pharmd, BCPS, BCSCP
Specialist in Sterile System Composition Services, Prisma Health
Clinical instructor by sterile composing, University of Caroline du Sud College of Pharmacy; Kennedy Pharmacy Innovation Center, Columbia, South Carolina
George Smith is a certified sterile security lawyer at the Commission who currently holds the position of specialist in the Sterile Composition Services of the System at Prisma Health, the largest health system in South Carolina. In addition, Dr. Smith is a clinical instructor by sterile composing for the Kennedy Pharmacy Innovation Center through the University of South Carolina College of Pharmacy and the director of Echelon Compounding LLC, a consulting company dedicated to the advancement of sterile composition. Dr. Smith is also an active participant The advisory group of the section on the composition of the ASHP section of hospital patients.
Glen Gard, CPHT-ADV, CSPT, FNHIA
National Director, sterile component and compliance in pharmacies, Care Health, Chicago, Illinois option
Glen Gard is the national director of compliance with composition and pharmacy for health options and is a member of the Illinois State Pharmacy Council. Mr. Gard is an inaugural member of the PTCB CSPT Development Development Committee. He is an active member of the ASHP having been chairman of the Executive Committee of the Pharmacy Technicians Forum and is a current member of the Education and Work Development Committee. In addition, Mr. Gard has been an active member of the NHIA and is currently vice-president of the Sterile Composition Practice Committee.
CE accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as A continuing pharmacy training supplier with praise.
Accredited for CPE
ACPE #: 0204-0000-24-401-l07-P / T
CE credit: 1 hour contact (0.1 CEU)
Activity type: Based on the application
Activity fees: At nochy
Supplied by ASHP.
Supported by an educational subsidy by Pfizer Inc.